Clinical trial
Oral Melatonin in Critically Ill High-risk Patients
NCT00470821 · University of Milan, Other · Completed
Key facts
| NCT number | NCT00470821 |
|---|---|
| Title | Oral Melatonin in Critically Ill High-risk Patients |
| Official title | Randomized, Controlled, Double Blind Trial to Evaluate Sedation and Quality of Life in High-risk, Critically Ill Patients Treated With Oral Melatonin |
| Lead sponsor | University of Milan, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Critically Ill Patients, Mechanically Ventilated Patients |
| Intervention type | Drug |
| Interventions | Oral melatonin 3mg BID, Placebo |
| Enrollment | 96 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | May 1, 2010 |
| First posted | May 8, 2007 |
| Last update posted | Jul 28, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: